TIANJIN PHARM DA REN TANG GRP
(SGX: T14)

TIANJIN ZHONGXIN PHARMACEUTICAL GROUP CORPORATION LIMITED is a China-based company mainly engaged in the development, manufacture and distribution of pharmaceutical products. The Company’s main products include Chinese patent medicines, western medicines, Chinese medicinal materials, pharmaceutical raw materials and preparations, biological medicines, dietary supplements and other products. The Company’s main products consist of drugs for treatment of cardiovascular diseases and enterogastritis, respiratory drugs, as well as antineoplastic drugs, among others. It distributes its products within domestic market and to overseas markets.

2.330 -

-0.010 (-0.43%)
Range 2.310 - 2.340   (1.30%)
Open 2.320
Previous Close 2.340
Bid Price 2.330
Bid Volume ('000) 23.4
Ask Price 2.340
Ask Volume ('000) 7.1
Volume ('000) 61.6
Value 143,335
Remark -
Delayed prices. Updated at 23 May 2025 17:04.
Data powered by

Upcoming Events

EGM

Meeting Date 09 June 2025
Meeting Time 2:00 PM
2.00 P.M. AT AN EGM OF THE COMPANY WILL BE HELD AT THE MEETING ROOM OF DA REN TANG MANSION, NO. 17 BAIDI ROAD, NANKAI DISTRICT, TIANJIN, THE PRC 300193 (CONCURRENTLY, VIA VIDEO CONFERENCING AT RNN CONFERENCE CENTRE, GB BUILDING,143 CECIL STREET, LEVEL 11, #11-03, SINGAPORE 069542 FOR HOLDERS OF THE S-SHARES IN SINGAPORE) ON MONDAY, 9 JUNE 2025 AT 2:00 P.M..

EGM

Meeting Date 09 June 2025
Meeting Time 2:00 PM
2.00 P.M. AT THE MEETING ROOM OF DA REN TANG MANSION, NO. 17 BAIDI ROAD, NANKAI DISTRICT, TIANJIN, THE PRC 300193 (CONCURRENTLY, VIA VIDEO CONFERENCING AT RNN CONFERENCE CENTRE, GB BUILDING,143 CECIL STREET, LEVEL 11, #11-03, SINGAPORE 069542 FOR HOLDERS OF THE S-SHARES IN SINGAPORE).
Data powered by SGX.
View Stock Calendar
View All Events

About TJ DaRenTang USD

TIANJIN ZHONGXIN PHARMACEUTICAL GROUP CORPORATION LIMITED is a China-based company mainly engaged in the development, manufacture and distribution of pharmaceutical products. The Company’s main products include Chinese patent medicines, western medicines, Chinese medicinal materials, pharmaceutical raw materials and preparations, biological medicines, dietary supplements and other products. The Company’s main products consist of drugs for treatment of cardiovascular diseases and enterogastritis, respiratory drugs, as well as antineoplastic drugs, among others. It distributes its products within domestic market and to overseas markets.

Loading Chart...

Please login to view stock data and analysis